Menu
Recruiting NCT02283112

Validation of Drug Assays in Various Biological Matrices

Observational Infection

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: antivirals, antimicrobials, oral contraceptive, erectile dysfunction agents.
Who it may be relevant to
Registry conditions: Infection. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study aims to ensure that assays that measure drug concentrations are accurate and precise in different matrices when quantified using high performance liquid chromatography -tandem mass spectrometry (HPLC-MS/MS). The study involves collecting samples of various bodily fluids to quantify antimicrobials, antivirals, oral contraceptives and erectile dysfunction agents. Samples will also be obtained from individuals not receiving these medications for quality control purposes.

Interventions

  • Other antivirals, antimicrobials, oral contraceptive, erectile dysfunction agents

Primary outcome measures

  • To measure drug concentrations using high performance liquid chromatography -tandem mass spectrometry (HPLC-MS/MS) (accuracy and precision of assays that measure drug concentrations) [Time frame: Follow up up to 5 years]

Eligibility criteria

Inclusion criteria

  • > 18 years of age

Exclusion criteria

  • Unable to give informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-only

Study locations

United Kingdom · 1 center
  • Royal Liverpool University Hospital — Liverpool

Identifiers

NCT: NCT02283112 · RLUH 4520

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗